Trial Outcomes & Findings for Circulation Improving Resuscitation Care (CIRC) (NCT NCT00597207)

NCT ID: NCT00597207

Last Updated: 2018-07-24

Results Overview

Whether a subject was discharged alive from the hospital or alternatively died prior to discharge.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

4231 participants

Primary outcome timeframe

From time of first contact until hospital discharge, up to 90 days.

Results posted on

2018-07-24

Participant Flow

Participant milestones

Participant milestones
Measure
iA-CPR
Integrated Mechanical CPR with AutoPulse All subjects initially receive manual chest compressions. After randomization, subjects randomized to iA-CPR are moved to the device once it is ready and from thereon receive mechanical chest compressions. AutoPulse: Mechanical device that provides chest compression
M-CPR
Manual CPR All subjects initially receive manual chest compressions. After randomization, subjects randomized to M-CPR continue to receive manual chest compressions. Manual: Manual chest compression
Overall Study
STARTED
2099
2132
Overall Study
COMPLETED
2094
2125
Overall Study
NOT COMPLETED
5
7

Reasons for withdrawal

Reasons for withdrawal
Measure
iA-CPR
Integrated Mechanical CPR with AutoPulse All subjects initially receive manual chest compressions. After randomization, subjects randomized to iA-CPR are moved to the device once it is ready and from thereon receive mechanical chest compressions. AutoPulse: Mechanical device that provides chest compression
M-CPR
Manual CPR All subjects initially receive manual chest compressions. After randomization, subjects randomized to M-CPR continue to receive manual chest compressions. Manual: Manual chest compression
Overall Study
Lost to Follow-up
5
7

Baseline Characteristics

Circulation Improving Resuscitation Care (CIRC)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
iA-CPR
n=2099 Participants
Integrated Mechanical CPR with AutoPulse All subjects initially receive manual chest compressions. After randomization, subjects randomized to iA-CPR are moved to the device once it is ready and from thereon receive mechanical chest compressions. AutoPulse: Mechanical device that provides chest compression
M-CPR
n=2132 Participants
Manual CPR All subjects initially receive manual chest compressions. After randomization, subjects randomized to M-CPR continue to receive manual chest compressions. Manual: Manual chest compression
Total
n=4231 Participants
Total of all reporting groups
Age, Customized
18-59 years
706 participants
n=5 Participants
734 participants
n=7 Participants
1440 participants
n=5 Participants
Age, Customized
60-74 years
671 participants
n=5 Participants
689 participants
n=7 Participants
1360 participants
n=5 Participants
Age, Customized
75+ years
722 participants
n=5 Participants
709 participants
n=7 Participants
1431 participants
n=5 Participants
Sex: Female, Male
Female
784 Participants
n=5 Participants
837 Participants
n=7 Participants
1621 Participants
n=5 Participants
Sex: Female, Male
Male
1315 Participants
n=5 Participants
1295 Participants
n=7 Participants
2610 Participants
n=5 Participants

PRIMARY outcome

Timeframe: From time of first contact until hospital discharge, up to 90 days.

Whether a subject was discharged alive from the hospital or alternatively died prior to discharge.

Outcome measures

Outcome measures
Measure
iA-CPR
n=2094 Participants
Integrated Mechanical CPR with AutoPulse All subjects initially receive manual chest compressions. After randomization, subjects randomized to iA-CPR are moved to the device once it is ready and from thereon receive mechanical chest compressions. AutoPulse: Mechanical device that provides chest compression
M-CPR
n=2125 Participants
Manual CPR All subjects initially receive manual chest compressions. After randomization, subjects randomized to M-CPR continue to receive manual chest compressions. Manual: Manual chest compression
Hospital Discharge
196 participants
233 participants

Adverse Events

iA-CPR

Serious events: 11 serious events
Other events: 242 other events
Deaths: 0 deaths

M-CPR

Serious events: 1 serious events
Other events: 225 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
iA-CPR
n=2099 participants at risk
Integrated Mechanical CPR with AutoPulse All subjects initially receive manual chest compressions. After randomization, subjects randomized to iA-CPR are moved to the device once it is ready and from thereon receive mechanical chest compressions. AutoPulse: Mechanical device that provides chest compression
M-CPR
n=2132 participants at risk
Manual CPR All subjects initially receive manual chest compressions. After randomization, subjects randomized to M-CPR continue to receive manual chest compressions. Manual: Manual chest compression
Injury, poisoning and procedural complications
CPR related injuries
0.52%
11/2099 • Number of events 11
0.05%
1/2132 • Number of events 1

Other adverse events

Other adverse events
Measure
iA-CPR
n=2099 participants at risk
Integrated Mechanical CPR with AutoPulse All subjects initially receive manual chest compressions. After randomization, subjects randomized to iA-CPR are moved to the device once it is ready and from thereon receive mechanical chest compressions. AutoPulse: Mechanical device that provides chest compression
M-CPR
n=2132 participants at risk
Manual CPR All subjects initially receive manual chest compressions. After randomization, subjects randomized to M-CPR continue to receive manual chest compressions. Manual: Manual chest compression
Injury, poisoning and procedural complications
Pneumothorax
1.6%
33/2099 • Number of events 33
0.94%
20/2132 • Number of events 20
Respiratory, thoracic and mediastinal disorders
Pulmonary edema
7.6%
159/2099 • Number of events 159
8.3%
176/2132 • Number of events 176
Injury, poisoning and procedural complications
Rib Fractures
3.3%
69/2099 • Number of events 69
1.5%
31/2132 • Number of events 31
Injury, poisoning and procedural complications
Subcutaneous emphysema
1.0%
21/2099 • Number of events 21
0.28%
6/2132 • Number of events 6

Additional Information

Sr. Director of Clinical Research

ZOLL Medical Corporation

Phone: 978-421-9655

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: LTE60